- 专利标题: Ketoreductase polypeptides
-
申请号: US16031177申请日: 2018-07-10
-
公开(公告)号: US10246687B2公开(公告)日: 2019-04-02
- 发明人: Emily Mundorff , Erik Jan De Vries
- 申请人: Codexis, Inc.
- 申请人地址: US CA Redwood City
- 专利权人: Codexis, Inc.
- 当前专利权人: Codexis, Inc.
- 当前专利权人地址: US CA Redwood City
- 代理机构: Codexis, Inc.
- 主分类号: C12N9/02
- IPC分类号: C12N9/02 ; C12N9/04 ; C07H21/04 ; C12P17/10 ; C12P7/02 ; C12P41/00 ; C12P17/14 ; C12N15/00 ; C12N15/75
摘要:
The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme including the capability of reducing 5-((4S)-2-oxo-4-phenyl (1,3-oxazolidin-3-yl))-1-(4-fluorophenyl) pentane-1,5-dione to (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize the intermediate (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one in a process for making Ezetimibe.
公开/授权文献
- US20180312817A1 KETOREDUCTASE POLYPEPTIDES 公开/授权日:2018-11-01
信息查询